Compare Gap Inc (GAP) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gap Inc vs Hims and Hers Health Inc — how do they compare? Gap Inc trades at $23.21 (market cap $8.21B), while Hims and Hers Health Inc trades at $28.46 (market cap $6.55B). The key difference: Gap Inc is the larger of the two by market cap, and Gap Inc pays a 3% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Gap Inc for 37 Days and Hims and Hers Health Inc for 21 Days on average.
| GAP | HIMS | |
|---|---|---|
Market Cap | $8.21B | $6.55B |
Volume | 5,192,917 | 14,842,814 |
Sector | Consumer Cyclical | Health |
52-Week High | $29.13 | $62.76 |
52-Week Low | $18.35 | $14.52 |
Typical Hold Time | 37 Days | 21 Days |
Enterprise Value | $11.44B | $7.25B |
Dividend Yield | 3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gap trades at $23.61, down 0.76% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $25.67. The stock shows strong fundamentals with a low P/E of 7.04, robust ROE of 33.78%, and net income margin expansion to 8.14% in 2025. Recent earnings beats in Q1 and Q2 2026 and strategic moves into music partnerships signal brand revitalization efforts.
The outlook is positive given undervaluation, earnings momentum, and strategic initiatives, but risks include reliance on Old Navy's turnaround and competitive pressures. Upside to the price target offers potential, supported by institutional buying interest and solid cash flow generation.
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gap Inc
Gap retails apparel, accessories, and personal-care products under the Gap, Old Navy, Banana Republic, and Athleta brands. Old Navy generates more than half of Gap's sales. The firm also operates e-commerce sites, outlet stores, and specialty stores under various Gap names. Gap operates nearly 3,000 stores in North America, Europe, and Asia and franchises about 600 stores in Asia, Europe, Latin America, and other regions. Gap was founded in 1969 and is based in San Francisco.
Read more on GAP →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
